Post-earnings recap
Reported
Thu, Aug 9, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Aurinia Pharmaceuticals reported a loss per share of $0.19, but the stock still rose by 1.87%. This increase may reflect investor sentiment or market conditions rather than strong financial performance, as no revenue figures were provided and no guidance was issued.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.19 | N/A | — |
| Revenue | — | N/A | — |
No transcript is on record for this earnings call, and the analysis is based solely on numerical results.